Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-051275

Chief Financial Officer sold 15,000 shares at an average $34.07 ($511,049)

  • Chief Financial Officer acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cohen Chad M · Chief Financial Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-10 Exercise or conversion : show line 1 in the form +5,000 $6.55 $32,750 26,604 D
2021-08-10 Sale : show line 2 in the form −5,000 $35.00 $175,000 21,604 D
2021-08-11 Exercise or conversion : show line 3 in the form +10,000 $6.55 $65,500 31,604 D
2021-08-11 Sale : show line 4 in the form −8,738 $33.48 $292,548 22,866 D
2021-08-11 Sale : show line 5 in the form −1,262 $34.47 $43,501 21,604 D
Open-market sales · 15,000 sh · avg $34.07 · $511,049

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-08-10 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −5,000 85,000 D
2021-08-11 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −10,000 75,000 D
Loading xslF345X03/doc4.xml…